UBE2L3
Ubiquitin-conjugating enzyme E2 L3
Also known as: UB2L3_HUMAN, UBCH7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P68036
- Gene
- UBE2L3
- Ensembl
- ENSG00000185651
- Chromosome
- 22
- Canonical length
- 154 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Primary cilium transition zone,Cytosol
OverviewNCBI Gene
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is demonstrated to participate in the ubiquitination of p53, c-Fos, and the NF-kB precursor p105 in vitro. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
154 residues, UniProt reviewed canonical sequence.
>P68036|UBE2L3
1 MAASRRLMKE LEEIRKCGMK NFRNIQVDEA NLLTWQGLIV PDNPPYDKGA FRIEINFPAE
61 YPFKPPKITF KTKIYHPNID EKGQVCLPVI SAENWKPATK TDQVIQSLIA LVNDPQPEHP
121 LRADLAEEYS KDRKKFCKNA EEFTKKYGEK RPVDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2L3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 64 nTPM
- spinal cord: 63 nTPM
- cerebral cortex: 62 nTPM
- amygdala: 62 nTPM
- midbrain: 60 nTPM
- hippocampal formation: 55 nTPM
Single-cell type
- extravillous trophoblasts: 248 nCPM
- late primary spermatocytes: 246 nCPM
- megakaryocytes: 241 nCPM
- syncytiotrophoblasts: 217 nCPM
- oocytes: 216 nCPM
- esophageal apical cells: 208 nCPM
Immune cell
- total PBMC: 86 nTPM
- myeloid DC: 71 nTPM
- plasmacytoid DC: 64 nTPM
- T-reg: 64 nTPM
- eosinophil: 63 nTPM
- intermediate monocyte: 62 nTPM
Brain region
- cerebral cortex: 70 nTPM
- pons: 65 nTPM
- thalamus: 63 nTPM
- medulla oblongata: 62 nTPM
- hypothalamus: 60 nTPM
- midbrain: 60 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0.84
- gnomAD missense Z
- 2.88
- DepMap mean gene effect
- -1.09
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell cycle phase transition
- cell population proliferation
- cellular response to glucocorticoid stimulus
- cellular response to steroid hormone stimulus
- positive regulation of protein targeting to mitochondrion
- positive regulation of protein ubiquitination
- protein K11-linked ubiquitination
- protein modification process
- protein polyubiquitination
- protein ubiquitination
- regulation of DNA-templated transcription
- ubiquitin-dependent protein catabolic process
Molecular functions
- ATP binding
- enzyme binding
- RNA binding
- transcription coactivator activity
- ubiquitin conjugating enzyme activity
- ubiquitin protein ligase binding
- ubiquitin-protein transferase activator activity
- ubiquitin-protein transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2L3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2L3 as an antibody target. Whether an autoantibody or antibody against UBE2L3 could matter depends on whether native UBE2L3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2L3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2L3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...